In 2025, seniors will pay less for 64 medications if they get them through Medicare Part B, which covers outpatient care, ...

AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...

The cost of prescription drugs is set to climb in 2025 and beyond, according to TD Cowen’s 30th Annual Drug Pricing survey.

Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate ...

Top Medicare Part D drugs without price negotiations have seen a 98% increase in list prices since their launch. Read more ...